| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.5 |